BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 38082244)

  • 1. Neuromuscular diseases associated with COVID-19 vaccines: a systematic review and pooled analysis of 258 patients.
    Tayebi A; Samimisedeh P; Jafari Afshar E; Mahmoudnia S; Milan N; Ayati A; Madady A; Rastad H
    BMC Neurol; 2023 Dec; 23(1):437. PubMed ID: 38082244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guillain-Barré syndrome after COVID-19 vaccination: A systematic review and analysis of case reports.
    Abuawwad MT; Taha MJJ; Taha AJ; Kozaa YA; Falah O; Abuawwad IT; Hammad EM; Mahmoud AA; Aladawi M; Serhan HA
    Clin Neurol Neurosurg; 2024 Mar; 238():108183. PubMed ID: 38401232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and outcomes of Myasthenia Gravis associated with COVID-19 vaccines: A systematic review and pooled analysis.
    Tayebi AH; Samimisedeh P; Jafari Afshar E; Ayati A; Ghalehnovi E; Foroutani L; Abbasi Khoshsirat N; Rastad H
    Medicine (Baltimore); 2023 Oct; 102(40):e34890. PubMed ID: 37800781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guillain-Barré syndrome after COVID-19 vaccines: A Tunisian case series.
    Berrim K; Lakhoua G; Zaiem A; Charfi O; Aouinti I; Kastalli S; Daghfous R; El Aidli S
    Br J Clin Pharmacol; 2023 Feb; 89(2):574-578. PubMed ID: 36398559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guillain-Barré syndrome in association with COVID-19 vaccination: a systematic review.
    Abolmaali M; Rezania F; Behnagh AK; Hamidabad NM; Gorji A; Mirzaasgari Z
    Immunol Res; 2022 Dec; 70(6):752-764. PubMed ID: 36098903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilateral facial palsy after COVID-19 vaccination.
    Andreozzi V; D'arco B; Pagliano P; Toriello A; Barone P
    Neurol Sci; 2022 Jul; 43(7):4069-4079. PubMed ID: 35364768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral facial palsy with paresthesias, variant of Guillain-Barré syndrome following COVID-19 vaccine: A case series of 9 patients.
    Castiglione JI; Crespo JM; Lecchini L; Silveira FO; Luis MB; Cotti N; Simison CJ; Aguirre F; Piedrabuena MA; Alonso RN; Azcona CL; Sosa PS; Maldonado E; Barroso F
    Neuromuscul Disord; 2022 Jul; 32(7):572-574. PubMed ID: 35644722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink.
    Hanson KE; Goddard K; Lewis N; Fireman B; Myers TR; Bakshi N; Weintraub E; Donahue JG; Nelson JC; Xu S; Glanz JM; Williams JTB; Alpern JD; Klein NP
    JAMA Netw Open; 2022 Apr; 5(4):e228879. PubMed ID: 35471572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and the peripheral nervous system. A 2-year review from the pandemic to the vaccine era.
    Taga A; Lauria G
    J Peripher Nerv Syst; 2022 Mar; 27(1):4-30. PubMed ID: 35137496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guillain-Barre syndrome following COVID-19 vaccines: A scoping review.
    Lahoz Fernandez PE; Miranda Pereira J; Fonseca Risso I; Baleeiro Rodrigues Silva P; Freitas Barboza IC; Vieira Silveira CG; Diogo Silva G; Marzorati Kuntz Puglia P; Genaro Mutarelli E
    Acta Neurol Scand; 2022 Apr; 145(4):393-398. PubMed ID: 34967005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guillain-Barré syndrome temporally associated with COVID-19 vaccines in Victoria, Australia.
    Osowicki J; Morgan HJ; Harris A; Clothier HJ; Buttery JP; Kiers L; Crawford NW;
    Vaccine; 2022 Dec; 40(52):7579-7585. PubMed ID: 36357291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Guillain-Barré Syndrome Following COVID-19 Vaccines: A Nationwide Self-Controlled Case Series Study.
    Le Vu S; Bertrand M; Botton J; Jabagi MJ; Drouin J; Semenzato L; Weill A; Dray-Spira R; Zureik M
    Neurology; 2023 Nov; 101(21):e2094-e2102. PubMed ID: 37788935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doctor-Should I get the COVID-19 vaccine? Infection and immunization in individuals with neuromuscular disorders.
    Živković SA; Gruener G; Narayanaswami P;
    Muscle Nerve; 2021 Mar; 63(3):294-303. PubMed ID: 33471383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of COVID-19 vaccine type on Guillain-Barré syndrome: Two cases and a literature review.
    Lee HY; Lien WC
    Hum Vaccin Immunother; 2023 Dec; 19(1):2171231. PubMed ID: 36919452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facial Nerve Paralysis and COVID-19: A Systematic Review.
    Namavarian A; Eid A; Ziai H; Cheng EY; Enepekides D
    Laryngoscope; 2023 May; 133(5):1007-1013. PubMed ID: 35938708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 vaccination and Guillain-Barré syndrome: analyses using the National Immunoglobulin Database.
    Keh RYS; Scanlon S; Datta-Nemdharry P; Donegan K; Cavanagh S; Foster M; Skelland D; Palmer J; Machado PM; Keddie S; Carr AS; Lunn MP;
    Brain; 2023 Feb; 146(2):739-748. PubMed ID: 35180300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 Vaccination and Neuroimmunological Disease: A Review.
    Willison AG; Pawlitzki M; Lunn MP; Willison HJ; Hartung HP; Meuth SG
    JAMA Neurol; 2024 Feb; 81(2):179-186. PubMed ID: 38227318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United States.
    Abara WE; Gee J; Marquez P; Woo J; Myers TR; DeSantis A; Baumblatt JAG; Woo EJ; Thompson D; Nair N; Su JR; Shimabukuro TT; Shay DK
    JAMA Netw Open; 2023 Feb; 6(2):e2253845. PubMed ID: 36723942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link?
    Oo WM; Giri P; de Souza A
    J Neuroimmunol; 2021 Nov; 360():577719. PubMed ID: 34560365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case with prolonged headache after COVID-19 vaccination and later developed Bell's palsy.
    Hsiao YY; Liu LJ; Lin YL
    Acta Neurol Taiwan; 2023 Jun; 32(2)():65-68. PubMed ID: 37198509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.